The Shanghai Stock Exchange has cancelled a hearing to review the Syngenta Group’s Yuan 65 billion ($9.4 billion at the current rate) planned initial share offering (IPO), Asian media report. The listing was slated to be on the Science and Technology Innovation Board of the Chinese Shanghai Stock Exchange (the STAR Market). The Shanghai exchange did not offer a reason for the cancellation, except saying that the decision was made as “situations meet the criteria laid out in the cancellation regulations”. As a part of the listing process, companies are required to appear before a panel for the hearing.
展开▼
